Executives from Industrial Plankton will be attending BioTaiwan June 28th - July 2nd

If you are in the area and would like to connect please contact

Click here for more information about BioTaiwan.

An invitation from the Chairman of BioTaiwan:

BioTaiwan 2017, the 15th annual biotech events is taking place this year June 28 - July 2 in Taipei, Taiwan. One of the largest gatherings of its kind in Asia is fully packed with five events in one includes the BioBusiness Asia conference for investment, conference on Greater China Opportunities, company presentations and one-on-one partnering, seminars, workshops and BioTaiwan Exhibition with 1,300+ booths from more than 600+ companies.

Taiwan is undergoing a boom in biotechnology, rewarding years of dedicated effort from its stakeholders. More and more locally-developed drugs are entering late-stage clinical trials, and new companies, service providers and manufacturing facilities are emerging to fill rapidly growing industry needs. Overseas interest is picking up as well, with licensing, partnering and investment agreements at an all-time high. The total market capitalization of local publicly-listed biotech companies has soared, increasing 700 percent since 2008
's capital market crash, rewarding stakeholders for their patience and support.
The biotech industry in Taiwan has a set of unique characteristics and strengths that make it an appealing prospect to the global life science community looking for partnership, investment or licensing opportunities. These include:
- Vibrant VC industry and capital markets
- Strong business and cultural ties to the Greater China market
- World-class clinical trial capability
- Transparent legal and business environment and strong IP protection
- Well established private-public partnerships with deep innovation pipeline
- Highly-educated, motivated and cost-effective workforce
- Executives with overseas training, global view and Big Pharma experience
- Strong government support, subsidies and tax breaks
As healthcare is moving from a
''one size fits all'' model towards a more personalized approach, bringing together Taiwan's newest diagnostic tools with precision therapeutics, existing strengths in ICT and device industries means that Taiwan is well placed to excel in this evolving healthcare ecosystem.
Save your dates and join us to experience the vibrancy, innovation and inspiration of Taiwan biotech industry and explore the tremendous opportunities on offer at BioTaiwan 2017!
Dr. Johnsee Lee,
Chairman, Taiwan BIO;
Chairman, BioTaiwan 2017 Organizing Committee